Enanta Pharmaceuticals Aktie
5,15
EUR
-0,25
EUR
-4,63
%
5,70
USD
-0,15
USD
-2,56
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG |
Werbung
Werbung